These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9097868)

  • 41. Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial.
    Oslin DW; Leong SH; Lynch KG; Berrettini W; O'Brien CP; Gordon AJ; Rukstalis M
    JAMA Psychiatry; 2015 May; 72(5):430-7. PubMed ID: 25760804
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Safety and effectiveness of opiate antagonist detoxification under general anesthesia].
    Ivaskevicius J; Jovaisa T; Laurinenas G; Vosylius S; Sipylaite J; Badaras R
    Medicina (Kaunas); 2005; 41(12):1011-8. PubMed ID: 16401957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial.
    Sharafaddinzadeh N; Moghtaderi A; Kashipazha D; Majdinasab N; Shalbafan B
    Mult Scler; 2010 Aug; 16(8):964-9. PubMed ID: 20534644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology.
    Naguy A; Alamiri B
    Psychopharmacol Bull; 2024 Jul; 54(3):97-99. PubMed ID: 38993658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Review of naltrexone, a long-acting opiate antagonist.
    Crabtree BL
    Clin Pharm; 1984; 3(3):273-80. PubMed ID: 6329589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
    Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predicting response to opiate antagonists and placebo in the treatment of pathological gambling.
    Grant JE; Kim SW; Hollander E; Potenza MN
    Psychopharmacology (Berl); 2008 Nov; 200(4):521-7. PubMed ID: 18581096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Long-acting naltrexone--a new way out of opiate addiction?].
    Stavseth LS; Kunøe N; Tanum L
    Tidsskr Nor Laegeforen; 2013 Nov; 133(21):2231-2. PubMed ID: 24226324
    [No Abstract]   [Full Text] [Related]  

  • 49. Opioids and social bonding: naltrexone reduces feelings of social connection.
    Inagaki TK; Ray LA; Irwin MR; Way BM; Eisenberger NI
    Soc Cogn Affect Neurosci; 2016 May; 11(5):728-35. PubMed ID: 26796966
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Study of hepatotoxicity of naltrexone in the treatment of alcoholism.
    Yen MH; Ko HC; Tang FI; Lu RB; Hong JS
    Alcohol; 2006 Feb; 38(2):117-20. PubMed ID: 16839858
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Naltrexone in the treatment of adolescent sexual offenders.
    Ryback RS
    J Clin Psychiatry; 2004 Jul; 65(7):982-6. PubMed ID: 15291688
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tolerability of naltrexone in treating older, alcohol-dependent patients.
    Oslin D; Liberto JG; O'Brien J; Krois S
    Am J Addict; 1997; 6(3):266-70. PubMed ID: 9256993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans.
    Walsh SL; Sullivan JT; Preston KL; Garner JE; Bigelow GE
    J Pharmacol Exp Ther; 1996 Nov; 279(2):524-38. PubMed ID: 8930154
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Opiate antagonists in erectile dysfunction: a possible new treatment option? Results of a pilot study with naltrexone.
    van Ahlen H; Piechota HJ; Kias HJ; Brennemann W; Klingmüller D
    Eur Urol; 1995; 28(3):246-50. PubMed ID: 8536780
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resolved: autistic children should have a trial of naltrexone.
    Campbell M; Harris JC
    J Am Acad Child Adolesc Psychiatry; 1996 Feb; 35(2):246-9; discussion 249-51. PubMed ID: 8720635
    [No Abstract]   [Full Text] [Related]  

  • 56. Naltrexone in organic bulimia: a preliminary report.
    Childs A
    Brain Inj; 1987; 1(1):49-55. PubMed ID: 3454671
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Low dose naltrexone for treatment of pain].
    Plesner KB; Vægter HB; Handberg G
    Ugeskr Laeger; 2015 Oct; 177(43):V03150248. PubMed ID: 26509454
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alleviation of both binge eating and sexual dysfunction with naltrexone.
    Meyer F
    J Clin Psychopharmacol; 2008 Dec; 28(6):722-3. PubMed ID: 19011456
    [No Abstract]   [Full Text] [Related]  

  • 59. Addition of naltrexone to fluoxetine in the treatment of binge eating disorder.
    Neumeister A; Winkler A; Wöber-Bingöl C
    Am J Psychiatry; 1999 May; 156(5):797. PubMed ID: 10327921
    [No Abstract]   [Full Text] [Related]  

  • 60. Naltrexone-induced augmentation of sexual response in men.
    Sathe RS; Komisaruk BR; Ladas AK; Godbole SV
    Arch Med Res; 2001; 32(3):221-6. PubMed ID: 11395188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.